Hilde Lavreysen

2.6k total citations
51 papers, 1.5k citations indexed

About

Hilde Lavreysen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Hilde Lavreysen has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Hilde Lavreysen's work include Neuroscience and Neuropharmacology Research (39 papers), Receptor Mechanisms and Signaling (31 papers) and Chemical Synthesis and Analysis (8 papers). Hilde Lavreysen is often cited by papers focused on Neuroscience and Neuropharmacology Research (39 papers), Receptor Mechanisms and Signaling (31 papers) and Chemical Synthesis and Analysis (8 papers). Hilde Lavreysen collaborates with scholars based in Belgium, United States and Netherlands. Hilde Lavreysen's co-authors include Anne Lesage, Xavier Langlois, Gary Tresadern, Andrés A. Trabanco, José M. Cid, Frank M. Dautzenberg, Josée E. Leysen, Gregor J. Macdonald, François Bischoff and Anton A. H. P. Megens and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hilde Lavreysen

51 papers receiving 1.5k citations

Peers

Countries citing papers authored by Hilde Lavreysen

Since Specialization

Citations

This map shows the geographic impact of Hilde Lavreysen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Lavreysen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Lavreysen more than expected).

Fields of papers citing papers by Hilde Lavreysen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Lavreysen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Lavreysen. The network helps show where Hilde Lavreysen may publish in the future.

Co-authorship network of co-authors of Hilde Lavreysen

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Lavreysen. A scholar is included among the top collaborators of Hilde Lavreysen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Lavreysen. Hilde Lavreysen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scaffold Hopping to Imidazo[1,2-a]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptor 2021 ·ACS Omega ·Ana Isabel de Lucas, Juan A. Vega, (unknown), María Lourdes Linares, Gary Tresadern, Hilde Lavreysen, Daniel Oehlrich, Andrés A. Trabanco, José M. Cid	2
2	Inhibition of the Alanine-Serine-Cysteine-1 Transporter by BMS-466442 2019 ·ACS Chemical Neuroscience ·Iván R. Torrecillas, (unknown), Ana Isabel de Lucas, (unknown), Andrés A. Trabanco, Hilde Lavreysen, Leonardo Pardo, Gary Tresadern	9
3	Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1H-benzimidazol-2-ones as mGlu₂ Receptor PAMs 2019 ·ACS Medicinal Chemistry Letters ·Ana Isabel de Lucas, Juan A. Vega, (unknown), María Lourdes Linares, (unknown), Gary Tresadern, Hilde Lavreysen, Andrés A. Trabanco, José M. Cid	8
4	Computationally Guided Identification of Allosteric Agonists of the Metabotropic Glutamate 7 Receptor 2018 ·ACS Chemical Neuroscience ·José M. Cid, Hilde Lavreysen, Gary Tresadern, Laura Pérez‐Benito, Fulgencio Tovar, Alberto Fontana, Andrés A. Trabanco	5
5	Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization 2018 ·Journal of Medicinal Chemistry ·(unknown), Xuesong Wang, (unknown), Luc Peeters, Laura Pérez‐Benito, Andrés A. Trabanco, Hilde Lavreysen, José M. Cid, Laura H. Heitman, Gary Tresadern, Adriaan P. IJzerman	21
6	Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 2017 ·Journal of Medicinal Chemistry ·(unknown), José M. Cid, (unknown), (unknown), (unknown), (unknown), Thea Mulder‐Krieger, Andrés A. Trabanco, A. Ahnaou, Wilhelmus Drinkenburg, Hilde Lavreysen, Laura H. Heitman, Adriaan P. IJzerman, Gary Tresadern	35
7	Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor 2017 ·Structure ·Laura Pérez‐Benito, (unknown), Arnau Cordomí, Luc Peeters, Hilde Lavreysen, Leonardo Pardo, Gary Tresadern	41
8	Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jesús Alcázar, (unknown), Silvia N. López, (unknown), (unknown), (unknown), (unknown), Hilde Lavreysen, Claire Mackie, Thomas M. Bridges, J. Scott Daniels, Colleen M. Niswender, Carrie K. Jones, Gregor J. Macdonald, Thomas Steckler, P. Jeffrey Conn, Shaun R. Stauffer, Craig W. Lindsley, José Manuel Bartolomé-Nebreda	7
9	Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5) 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), José Manuel Bartolomé-Nebreda, (unknown), (unknown), Silvia N. López, (unknown), (unknown), Hilde Lavreysen, Gregor J. Macdonald, Thomas Steckler, Claire Mackie, Thomas M. Bridges, J. Scott Daniels, Colleen M. Niswender, Meredith J. Noetzel, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Shaun R. Stauffer	6
10	mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats 2015 ·PLoS ONE ·A. Ahnaou, Hilde Lavreysen, Gary Tresadern, José M. Cid, Wilhelmus Drinkenburg	14
11	Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Hilde Lavreysen, Xavier Langlois, A. Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, (unknown), Ilse Van der Linden, Luc Peeters, Anton A. H. P. Megens, Cindy Wintmolders, José M. Cid, Andrés A. Trabanco, José Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor J. Macdonald, John Atack	53
12	Differential Interaction of Neuroleptics with Apomorphine-Induced Behavior in Rats as a Function of Changing Levels of Dopamine Receptor Stimulation 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Anton Megens, (unknown), Hilde Lavreysen, Xavier Langlois	1
13	Discovery and SAR of a novel series of non-MPEP site mGlu5 PAMs based on an aryl glycine sulfonamide scaffold 2012 ·Bioorganic & Medicinal Chemistry Letters ·Alice L. Rodriguez, Ya Zhou, Richard D. Williams, C. David Weaver, Paige N. Vinson, Eric S. Dawson, Thomas Steckler, Hilde Lavreysen, Claire Mackie, (unknown), Gregor J. Macdonald, J. Scott Daniels, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Shaun R. Stauffer	11
14	Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function 2011 ·Molecular Pharmacology ·Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Hyekyung P. Cho, Emily Days, (unknown), Alice L. Rodriguez, Hilde Lavreysen, Shaun R. Stauffer, Colleen M. Niswender, Zixiu Xiang, J. Scott Daniels, Carrie K. Jones, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn	99
15	Metabotropic Glutamate Receptors: Their Therapeutic Potential in Anxiety 2010 ·Current topics in behavioral neurosciences ·Will Spooren, Anne Lesage, Hilde Lavreysen, F. Gasparini, Thomas Steckler	37
16	Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor 2009 ·Bioorganic & Medicinal Chemistry Letters ·Gary Tresadern, José M. Cid, Gregor J. Macdonald, Juan A. Vega, Ana Isabel de Lucas, (unknown), (unknown), María Lourdes Linares, Daniel Oehlrich, Hilde Lavreysen, (unknown), Andrés A. Trabanco	58
17	In vitro and in vivo activities of the mGlu1 receptor negative allosteric modulator JNJ16259685 2005 ·Neuropharmacology ·(unknown), Hilde Lavreysen, Arjan Buist, Xavier Langlois, Jos Prickaerts, Anton Megens, Theo Meert, Thomas Steckler	3
18	Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test 2004 ·Psychopharmacology ·Thomas Steckler, Hilde Lavreysen, Ana M.M. Oliveira, (unknown), Hansfried Van Craenendonck, Jos Prickaerts, Anton A. H. P. Megens, Anne Lesage	79
19	Effects of mGlu(1) receptor antagonism on anxiety-related behaviour in the rat lick suppression test 2003 ·Behavioural Pharmacology ·Thomas Steckler, (unknown), Hansfried Van Craenendonck, Hilde Lavreysen, Theo Meert, (unknown)	1
20	[3H]R214127: A Novel High-Affinity Radioligand for the mGlu1 Receptor Reveals a Common Binding Site Shared by Multiple Allosteric Antagonists 2003 ·Molecular Pharmacology ·Hilde Lavreysen, (unknown), François Bischoff, Xavier Langlois, Josée E. Leysen, Anne Lesage	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact